Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Breast Cancer Diagnostics Market 

5.1. COVID-19 Landscape: Breast Cancer Diagnostics Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Breast Cancer Diagnostics Market, By Product

8.1. Breast Cancer Diagnostics Market, by Product Type, 2023-2032

8.1.1. Platform-based Products

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. Instrument-based Products

8.1.2.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global Breast Cancer Diagnostics Market, By Type

9.1. Breast Cancer Diagnostics Market, by Type, 2023-2032

9.1.1. Imaging

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. Biopsy

9.1.2.1. Market Revenue and Forecast (2020-2032)

9.1.3. Genomic Tests

9.1.3.1. Market Revenue and Forecast (2020-2032)

9.1.4. Blood Tests

9.1.4.1. Market Revenue and Forecast (2020-2032)

9.1.5. Others

9.1.5.1. Market Revenue and Forecast (2020-2032)

Chapter 10. Global Breast Cancer Diagnostics Market, By Application Type 

10.1. Breast Cancer Diagnostics Market, by Application Type, 2023-2032

10.1.1. Screening

10.1.1.1. Market Revenue and Forecast (2020-2032)

10.1.2. Diagnostic and Predictive

10.1.2.1. Market Revenue and Forecast (2020-2032)

10.1.3. Prognostic

10.1.3.1. Market Revenue and Forecast (2020-2032)

10.1.4. Others

10.1.4.1. Market Revenue and Forecast (2020-2032)

Chapter 11. Global Breast Cancer Diagnostics Market, By End Use Type 

11.1. Breast Cancer Diagnostics Market, by End Use Type, 2023-2032

11.1.1. Hospitals & Clinics

11.1.1.1. Market Revenue and Forecast (2020-2032)

11.1.2. Diagnostic Centers & Medical Laboratories

11.1.2.1. Market Revenue and Forecast (2020-2032)

11.1.3. Others

11.1.3.1. Market Revenue and Forecast (2020-2032)

Chapter 12. Global Breast Cancer Diagnostics Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Product (2020-2032)

12.1.2. Market Revenue and Forecast, by Type (2020-2032)

12.1.3. Market Revenue and Forecast, by Application Type (2020-2032)

12.1.4. Market Revenue and Forecast, by End Use Type (2020-2032)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Product (2020-2032)

12.1.5.2. Market Revenue and Forecast, by Type (2020-2032)

12.1.5.3. Market Revenue and Forecast, by Application Type (2020-2032)

12.1.5.4. Market Revenue and Forecast, by End Use Type (2020-2032)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Product (2020-2032)

12.1.6.2. Market Revenue and Forecast, by Type (2020-2032)

12.1.6.3. Market Revenue and Forecast, by Application Type (2020-2032)

12.1.6.4. Market Revenue and Forecast, by End Use Type (2020-2032)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Product (2020-2032)

12.2.2. Market Revenue and Forecast, by Type (2020-2032)

12.2.3. Market Revenue and Forecast, by Application Type (2020-2032)

12.2.4. Market Revenue and Forecast, by End Use Type (2020-2032)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Product (2020-2032)

12.2.5.2. Market Revenue and Forecast, by Type (2020-2032)

12.2.5.3. Market Revenue and Forecast, by Application Type (2020-2032)

12.2.5.4. Market Revenue and Forecast, by End Use Type (2020-2032)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Product (2020-2032)

12.2.6.2. Market Revenue and Forecast, by Type (2020-2032)

12.2.6.3. Market Revenue and Forecast, by Application Type (2020-2032)

12.2.6.4. Market Revenue and Forecast, by End Use Type (2020-2032)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Product (2020-2032)

12.2.7.2. Market Revenue and Forecast, by Type (2020-2032)

12.2.7.3. Market Revenue and Forecast, by Application Type (2020-2032)

12.2.7.4. Market Revenue and Forecast, by End Use Type (2020-2032)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Product (2020-2032)

12.2.8.2. Market Revenue and Forecast, by Type (2020-2032)

12.2.8.3. Market Revenue and Forecast, by Application Type (2020-2032)

12.2.8.4. Market Revenue and Forecast, by End Use Type (2020-2032)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Product (2020-2032)

12.3.2. Market Revenue and Forecast, by Type (2020-2032)

12.3.3. Market Revenue and Forecast, by Application Type (2020-2032)

12.3.4. Market Revenue and Forecast, by End Use Type (2020-2032)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Product (2020-2032)

12.3.5.2. Market Revenue and Forecast, by Type (2020-2032)

12.3.5.3. Market Revenue and Forecast, by Application Type (2020-2032)

12.3.5.4. Market Revenue and Forecast, by End Use Type (2020-2032)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Product (2020-2032)

12.3.6.2. Market Revenue and Forecast, by Type (2020-2032)

12.3.6.3. Market Revenue and Forecast, by Application Type (2020-2032)

12.3.6.4. Market Revenue and Forecast, by End Use Type (2020-2032)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Product (2020-2032)

12.3.7.2. Market Revenue and Forecast, by Type (2020-2032)

12.3.7.3. Market Revenue and Forecast, by Application Type (2020-2032)

12.3.7.4. Market Revenue and Forecast, by End Use Type (2020-2032)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Product (2020-2032)

12.3.8.2. Market Revenue and Forecast, by Type (2020-2032)

12.3.8.3. Market Revenue and Forecast, by Application Type (2020-2032)

12.3.8.4. Market Revenue and Forecast, by End Use Type (2020-2032)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Product (2020-2032)

12.4.2. Market Revenue and Forecast, by Type (2020-2032)

12.4.3. Market Revenue and Forecast, by Application Type (2020-2032)

12.4.4. Market Revenue and Forecast, by End Use Type (2020-2032)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Product (2020-2032)

12.4.5.2. Market Revenue and Forecast, by Type (2020-2032)

12.4.5.3. Market Revenue and Forecast, by Application Type (2020-2032)

12.4.5.4. Market Revenue and Forecast, by End Use Type (2020-2032)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Product (2020-2032)

12.4.6.2. Market Revenue and Forecast, by Type (2020-2032)

12.4.6.3. Market Revenue and Forecast, by Application Type (2020-2032)

12.4.6.4. Market Revenue and Forecast, by End Use Type (2020-2032)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Product (2020-2032)

12.4.7.2. Market Revenue and Forecast, by Type (2020-2032)

12.4.7.3. Market Revenue and Forecast, by Application Type (2020-2032)

12.4.7.4. Market Revenue and Forecast, by End Use Type (2020-2032)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Product (2020-2032)

12.4.8.2. Market Revenue and Forecast, by Type (2020-2032)

12.4.8.3. Market Revenue and Forecast, by Application Type (2020-2032)

12.4.8.4. Market Revenue and Forecast, by End Use Type (2020-2032)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Product (2020-2032)

12.5.2. Market Revenue and Forecast, by Type (2020-2032)

12.5.3. Market Revenue and Forecast, by Application Type (2020-2032)

12.5.4. Market Revenue and Forecast, by End Use Type (2020-2032)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Product (2020-2032)

12.5.5.2. Market Revenue and Forecast, by Type (2020-2032)

12.5.5.3. Market Revenue and Forecast, by Application Type (2020-2032)

12.5.5.4. Market Revenue and Forecast, by End Use Type (2020-2032)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Product (2020-2032)

12.5.6.2. Market Revenue and Forecast, by Type (2020-2032)

12.5.6.3. Market Revenue and Forecast, by Application Type (2020-2032)

12.5.6.4. Market Revenue and Forecast, by End Use Type (2020-2032)

Chapter 13. Company Profiles

13.1. Genomic Health

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. NanoString Technologies Inc.

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Paragon Biosciences LLC

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Devicor Medical Products Inc.

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. AstraZeneca

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Quest Diagnostics Incorporated

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Koninklijke Philips N.V.

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Siemens AG

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Biocept Inc.

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Epigenomics Inc.

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms